Lipid composition heatmap for Study ST003917

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Age_at_screening (years):1.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.1 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):1.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.2 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):2.4 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.6 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):2.7 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.7 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.7 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):2.8 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.1 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.2 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.2 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.2 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.3 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.4 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Female | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.5 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R+ | Remission:Yes | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.6 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.7 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.7 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.7 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:Baseline | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Avoidance | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R+ | Remission:Yes | Desensitized:Yes
Age_at_screening (years):3.9 | Sex:Male | Visit:End of Treatment | Treatment:Placebo | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D-R- | Remission:No | Desensitized:No
Age_at_screening (years):3 | Sex:Female | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):3 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:Baseline | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:End of Avoidance | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Age_at_screening (years):4 | Sex:Male | Visit:End of Treatment | Treatment:Peanut OIT | Tolerance_Outcome:D+R- | Remission:No | Desensitized:Yes
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines28
Cer5
DAG13
DHCer1
Hex2Cer2
HexCer2
LPC4
LPE8
LPG4
LPI4
LPS2
MAG9
MGDG4
O-LPE3
PC4
Saturated FA15
SM2
Unsaturated FA22
  logo